Most of the popular protocol is borrowed from a clinical population and applied to healthy people without comment.

You have two changes at once here. You cannot attribute anything until one of them moves. Same for me with kratom, unfortunately.

Everyone here blames the drug. Half the time it is the appointment schedule, not the molecule.

Worth asking what specifically was measured. Pain scores move with mood and function does not.

Imprint databases are mostly US-centric. A confident hit for another market is still a guess.

Where does the human data stop and the extrapolation begin? That is the whole thread. Same for me with fish oil, unfortunately.